OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
August 28, 2018
The company is certified as a manufacturer of pressure vessels and components for use in China.
An expansion of laboratory facilities in Geneva, Switzerland expands SGS services for high-order structure analysis.
August 24, 2018
The new Testa Center in Uppsala, Sweden is a collaborative test bed offering biotechnology equipment from GE Healthcare for process development.
August 14, 2018
Drug product approval from FDA follows previous approvals from European and Japanese authorities.
August 02, 2018
Industry experts discuss the challenges of performing glycan analysis and how companies can gain specific expertise from outsourcing partners.
August 01, 2018
API can be mixed with silicone and other polymers to create drug-delivery combination products.
CMOs have been active over the past year in expanding their biologics production and capabilities.
This article provides a sampling of the latest investments, expansions, and acquisitions by small-molecule contract service providers.
Heightened uncertainty means CDMO executives need to play out planning scenarios.
Why shouldn’t biopharmaceutical manufacturers be able to leverage standardized construction practices to improve time to market?